peopleInnovationCareers RarePipelineCollaborationFinanceAdvance treatment Skip to main contentSkip to navigationSkip to search
Hansa Biopharma
HNSA (, %) SEK
Hansa Biopharma
Financial documents

Shareholders

Shareholders

Top 10 shareholders as of March 31, 2024.

 NameNumber of sharesOwnership in pct
Redmile Group, LLC9,647,74718.3%
Nexttobe AB2,155,3794.1%
Jeansson, Theodor2,150,0004.1%
Olausson, Thomas1,917,0003.6%
Försäkrings AB Avanza Pension1,799,5173.4%
Fjärde AP-Fonden (AP 4)1,700,0003.2%
Tredje AP-Fonden (AP 3)1,389,6502.6%
Braidwell, L.P.867,5301.6%
VOB & T Trading AB644,8001.2%
Max Mitteregger Kapitalförvaltning AB600,0001.1%
Other29,800,17356.6%
Total52,671,796100.0%

Source: S&P Global compiled and processed data from various sources, including Euroclear, Morningstar, Factset and the Swedish Financial Supervisory Authority (Finansinspektionen).

Hansa Biopharma had approximately 20,000 shareholders as of March 31, 2024.

Classification of ownership as per Januari 31, 2024.

Region

52%
19%
29%

Category

33%
30%
24%
13%